| ABOS Stock | | | USD 2.67 -0.25 -8.56% |
The Market Risk Adjusted Performance calculation for Acumen Pharmaceuticals draws on price and volume history. All inputs are based on actual trading observations from supported exchanges. Acumen Pharmaceuticals has a market cap of 161.73 M, ROE of -85.93%.
Trending Equities adds portfolio-level perspective. The portfolio reflects a holding in Acumen Pharmaceuticals. The weighting is visible within the allocation breakdown. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in metropolitan statistical area.
Discover how to invest in Acumen Stock by reading our
How to Buy Acumen Stock guide. It offers practical guidance on account setup, order types, and timing for Acumen Pharmaceuticals. Use it as a practical starting point for your Acumen Stock investment research.
Acumen Pharmaceuticals has current Market Risk Adjusted Performance of 1.18.
Acumen Pharmaceuticals maintains a
second standing in market risk adjusted performance relative to competitors. It is currently under evaluation in maximum drawdown relative to competitors yielding
32.87 of Maximum Drawdown per Market Risk Adjusted Performance. For Acumen Pharmaceuticals, Maximum Drawdown stands at
32.87 times Market Risk Adjusted Performance